Pancreatic Cancer Research

Clinical trialObservationalRecruiting

Management and Outcomes of Local Complications of Acute Pancreatitis and Postoperative Pancreatic Fistula

WONDERFUL Registry: A Multicenter Prospective Observational Study of Local Complications of Acute Pancreatitis and Postoperative Pancreatic Fistula

Outcome
Ongoing
Phase
Observational
Status
Recruiting
Study type
Observational
Start
14 September 2023
Expected end
31 July 2028
Enrollment
5,000 participants
Sites
12
Primary outcomes
Proportion of Participants Achieving Clinical Success Within 180 Days
Sponsor type
Academic / other
Results posted
No
Last update
7 October 2026

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This multicenter prospective observational registry will evaluate the clinical characteristics and treatment outcomes of adults with local complications of acute pancreatitis or postoperative pancreatic fistula. Data generated during routine clinical care, including patient characteristics, imaging findings, treatments, adverse events, recurrence, and clinical outcomes, will be collected. Treatment is determined by the treating physicians and is not assigned by the study protocol.

Detailed description public domain (ClinicalTrials.gov)

Local complications of acute pancreatitis, including pancreatic and peripancreatic fluid collections, may require conservative management, endoscopic or percutaneous drainage, necrosectomy, or surgery. Similar fluid collections may occur after pancreatic surgery as a result of postoperative pancreatic fistula. Evidence regarding treatment selection, timing, and outcomes remains limited because individual centers encounter relatively few cases. This prospective multicenter registry will collect clinical, laboratory, imaging, treatment, and outcome data generated during routine care. The primary objective is to evaluate clinical success within 180 days after enrollment. Secondary objectives include technical success, adverse events, additional interventions, recurrence, mortality, and healthcare utilization. Exploratory analyses will evaluate patient, disease, imaging, and treatment factors associated with clinical outcomes. No diagnostic or therapeutic intervention is assigned by the study protocol.